XML 128 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings per Common Share (Tables)
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2021
Schedule of basic and diluted per share of common stock    

The computations of the numerator to derive the basic and diluted earnings per share amounts presented on the face of the accompanying consolidated statements of operations are as follows (in thousands):

 

     Years Ended March 31,  
     2021      2020  

Loss from continuing operations, net of tax

    $ (900,233 )     $ (568,110 ) 

Net loss from continuing operations, net of tax, attributable to noncontrolling interest

      (90,999 )       (48,716 ) 
  

 

 

     

 

 

  

Loss from continuing operations, net of tax, attributable to Roivant Sciences Ltd.

      (809,234 )       (519,394 ) 

Deemed dividend on repurchase of redeemable noncontrolling interest relating to subsidiary convertible and redeemable preferred stock(1)

      —          (77,777 ) 
  

 

 

     

 

 

  

Basic and diluted loss from continuing operations, net of tax, attributable to Roivant Sciences Ltd.

    $ (809,234 )     $ (597,171 ) 
  

 

 

     

 

 

  

Income from discontinued operations, net of tax

    $ —      $ 1,578,426

Net loss from discontinued operations, net of tax, attributable to noncontrolling interest

      —          (141,477 ) 
  

 

 

     

 

 

  

Net income from discontinued operations, net of tax, attributable to Roivant Sciences Ltd.

    $ —      $ 1,719,903
  

 

 

     

 

 

  

Basic and diluted income from discontinued operations, net of tax

    $ —      $ 1,719,903
  

 

 

     

 

 

  

Basic and diluted net (loss) income attributable to Roivant Sciences

    $ (809,234 )     $ 1,122,732
  

 

 

     

 

 

  

 

(1)

Consideration paid in excess of carrying value for the repurchase of redeemable noncontrolling interest relating to subsidiary convertible and redeemable preferred stock of $77.8 million is considered a deemed dividend and, for purposes of calculating net loss per share, increases the loss from continuing operations, net of tax, attributable to Roivant Sciences Ltd. for the year ended March 31, 2020. See Note 10, “Shareholders’ Equity and Redeemable Noncontrolling Interest.”
Montes Archimedes Acquisition Corp.      
Schedule of basic and diluted per share of common stock

The following table reflects the calculation of basic and diluted net income per common share:

 

     For the
Three
Months
Ended
March 31,
2021		  

Class A Common stock subject to possible redemption

   

Numerator: Earnings allocable to Common stock subject to possible redemption

   

Income from investments held in Trust Account

    $ 82,038  

Less: Company’s portion available to be withdrawn to pay taxes

      (60,788 ) 
  

 

 

  

Net income attributable

    $ 21,250  
  

 

 

  

Denominator: Weighted average Class A common stock subject to possible redemption

   

Basic and diluted weighted average shares outstanding

      34,396,710  
  

 

 

  

Basic and diluted net income per share

    $ 0.00  
  

 

 

  

Non-Redeemable Common Stock

   

Numerator: Net Loss minus Net Earnings

   

Net gain

    $ 19,019,100  

Less: Net income allocable to Class A common stock subject to possible redemption

      (21,250 ) 
  

 

 

  

Non-redeemable net gain

    $ 18,997,850  
  

 

 

  

Denominator: weighted average Non-redeemable common stock

   

Basic and diluted weighted average shares outstanding, Non-redeemable common stock

      16,943,069  
  

 

 

  

Basic and diluted net income per share, Non-redeemable common stock

    $ 1.12  
  

 

 

  

The following table reflects the calculation of basic and diluted net income (loss) per common share:

 

     For the Period
from July 6,
2020
(inception)
through
December 31,
2020		  

Class A Common stock subject to possible redemption

   

Numerator: Earnings allocable to Common stock subject to possible redemption

   

Income from investments held in trust Account

    $ 71,296  

Less: Company’s portion available to be withdrawn to pay taxes

    $ (71,296 ) 
  

 

 

  

Net income attributable

    $ —    
  

 

 

  

Denominator: Weighted average Class A common stock subject to possible redemption

   

Basic and diluted weighted average shares outstanding

      34,386,548  
  

 

 

  

Basic and diluted net income per share

    $ —    
  

 

 

  
Non-Redeemable Common Stock   

Numerator: Net Loss minus Net Earnings

   

Net loss

    $ (10,774,318 ) 

Net income allocable to Class A common stock subject to possible redemption

      —    
  

 

 

  

Non-redeemable net loss

    $ (10,774,318 ) 
  

 

 

  

Denominator: weighted average Non-redeemable common stock

   

Basic and diluted weighted average shares outstanding, Non-redeemable common stock

      13,324,191  
  

 

 

  

Basic and diluted net loss per share, Non-redeemable common stock

    $ (0.81 )